HCV HIV +*+ Human immunodeficiency virus HIV hepatitis C virus HCV HIV HCV HCV HIV HIV

Size: px
Start display at page:

Download "HCV HIV +*+ Human immunodeficiency virus HIV hepatitis C virus HCV HIV HCV HCV HIV HIV"

Transcription

1 ,**- The Japanese Society for AIDS Research The Journal of AIDS Research +0 HIV HCV , +, :HCV HIV HAART / : +*+ +*0,**- Human immunodeficiency virus HIV hepatitis C virus HCV HIV,* HCV HIV HCV HIV HCV HIV HCV highly active antiretroviral therapy HAART HIV HIV HCV HIV HCV C National Institutes of Health Consensus Development Conference C /,**, HCV HIV, HCV HIV - 1 HCV HIV HAART HCV 2 :.00 2//* 0/ Fax : */, 1..,+12,** HCV HIV HIV n +* HCV n 0* HCV HIV n,3 - n -*. HAART HCV HIV GPT, IgM, IgA, IgG, B CD. T HIV Amplicor-HIV monitor assay Roche Diagnostic Systems, Tokyo, Japan HCV Quantiplex HCV RNA Chiron, Emeryville, CA Student t test Wilcoxon test, t-test Spearman rank test P *.*/ HAART HIV HCV + HCV HCV HCV HIV HIV HCV HAART GPT, IgM, IgA, IgG, B CD. T., GPT HCV HIV HCV HCV GPT IgM B HCV HIV HCV GPT HCV CD. T HCV HIV HIV HCV HIV IgA HIV HCV HIV HIV +*+ -+

2 K Hayashi et al. : Liver Damage Related with Hepatitis C and Human Immune Deficiency Coinfection + HAART HCV HIV IgG HIV, HCV - HAART HIV HCV B CD. T HIV CD. T HCV B, HIV HCV GPT, IgM, IgA, IgG, B CD. T HAART., / HAART HCV HIV HIV HIV CD. T HCV HAART B IgM HCV HIV CD. T HCV B HIV T HCV B C HCV HCV HIV 3 HAART HIV HCV HAART HCV HAART HIV HCV HIV HAART HCV +* HAART ++ HCV HIV HCV HCV HIV +32* HIV HCV HIV HCV IFN HIV HAART IFN HCV +,, +- IFN IFN HAART HCV IFN Vento HCV IFN HAART HCV HIV IFN HCV HCV IFN +. HCV HIV IFN IFN HCV HIV HAART HCV HIV + Bica I, McGovern B, Dhar R, Stone D, McGowan K, Scheib R, Snydman DR : Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis -, :.3,.31,,**+., Thomas DL : Hepatitis C andhuman immunodeficiency virus infection. Hepatology -0 :S,*+,*3,,**,. - Pol S, Vallet-PichardA, Fontaine H : Hepatitis C and +*, -,

3 The Journal of AIDS Research Vol. / No.,,**- +*- --

4 K Hayashi et al. : Liver Damage Related with Hepatitis C and Human Immune Deficiency Coinfection +*. -.

5 The Journal of AIDS Research Vol. / No.,,**-. CD., B cell, HIV RNA, IgA human immune deficiency coinfection at the era of highly active antiretroviral therapy. J Viral Hepat 3 : + 2,,**,.. Bruno R, Sacchi P, Puoti M, Soriano V, Filice G: HCV chronic hepatitis in patients with HIV : clinical management issues. Am J Gastroenterol 31 : +/32 +0*0,,**,. / Maier I, Wu GY : Hepatitis C and HIV co-infection : a review.world J Gastroenterol 2 : /11 /13,,**,. 0 Mohsen AH, Easterbrook P, Taylor CB, Norris S : Hepatitis C and HIV-+ coinfection. Gut /+ : 0*+ 0*2,,**,. 1 Sulkowski MS, Thomas DL : Hepatitis C in the HIV- Infected Person. Ann Intern Med +-2 : +31,*1,,**-. 2 Yokozaki S, Takamatsu J, Nakano I, Katano Y, Toyoda H, Hayashi K, Hayakawa T, Fukuda Y : Immunologic dynamics in hemophiliac patients infected with hepatitis C virus and human immunodeficiency virus : influence of antiretroviral therapy. Blood 30 :.,3-.,33,,***. 3 Eyster ME, Fried MW, Di Bisceglie AM, Goedert JJ : Increasing hepatitis C virus RNA levels in hemophiliacs : Relationship to human immunodeficiency virus infection and liver disease. Blood 2. : +*,* +*,-, * Rutschmann OT, Negro F, Hirschel B, Hadengue A, Anwar D, Perrin LH : Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV. J Infect Dis +11 : 12-12/, Vento S, Garofano T, Renzini C, Casali F, Ferraro T, Concia E : Enhancement of hepatitis C virus replication and liver damage in HIV-coinfected patients on antiretroviral combination therapy. AIDS +, : , , Toyoda H, Nakano S, Kumada T, Takeda I, Sugiyama K, Osada T, Kiriyama S, Orito E, Mizokami M : Comparison of serum hepatitis C virus RNA concentration by branched DNA probe assay with competitive reverse transcription polymerase chain reaction as a predictor of response to interferon-alpha therapy in chronic hepatitis C patients. J Med Virol.2 : -/. -/3, Di Bisceglie AM, Hoofnagle JH : Optimal therapy of hepatitis C. Hepatology -0 :S+,+ +,1,,**,. +. Yoshida H, Arakawa Y, Sata M, Nishiguchi S, Yano M, Fujiyama S, Yamada G, Yokosuka O, Shiratori Y, Omata M : Interferon therapy prolonged life expectancy among chronic hepatitis C patients. Gastroenterology +,- :.2-.3+,,**,. +*/ -/

6 K Hayashi et al. : Liver Damage Related with Hepatitis C and Human Immune Deficiency Coinfection / GPT, HCV RNA, IgM, IgG +*0-0

Papers. Clinical application of the Quantiplex HCV RNA 2.0 and Amplicor HCV Monitor assays for quantifying serum hepatitis C virus RNA

Papers. Clinical application of the Quantiplex HCV RNA 2.0 and Amplicor HCV Monitor assays for quantifying serum hepatitis C virus RNA J Clin Pathol 1999;52:807 811 807 Papers Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical College Hospital, No 100, Shih-Chuan 1st Rd, Kaohsiung, Taiwan, Republic of China M-L

More information

HIV. KEY WORDS: HIV, esophageal varices, endoscopic injection sclerotherapy (EIS), endoscopic variceal ligation (EVL)

HIV. KEY WORDS: HIV, esophageal varices, endoscopic injection sclerotherapy (EIS), endoscopic variceal ligation (EVL) 2013; 19: 25 32 HIV 1, 2 1 1 1 1 HIV 7 3 HCV, 2 HBV B C 2 HCC 2 F 2 RC 1 2.1 F 1 RC 0 30.4 4 HCV 9 HCC 13.5 3 HCC 1 1 AIDS B C HIV HIV HCV HIV KEY WORDS: HIV, esophageal varices, endoscopic injection sclerotherapy

More information

Kenneth E. Sherman, 1 Norah J. Shire, 1 Paul Cernohous, 2 Susan D. Rouster, 1 Janice H. Omachi, 2 Scott Brun, 2 and Barbara Da Silva 2

Kenneth E. Sherman, 1 Norah J. Shire, 1 Paul Cernohous, 2 Susan D. Rouster, 1 Janice H. Omachi, 2 Scott Brun, 2 and Barbara Da Silva 2 HIV/AIDS MAJOR ARTICLE Liver Injury and Changes in Hepatitis C Virus (HCV) RNA Load Associated with Protease Inhibitor Based Antiretroviral Therapy for Treatment-Naive HCV-HIV Coinfected Patients: Lopinavir-Ritonavir

More information

Changes in Hepatitis C Virus (HCV) Antibody Status in Patients with Chronic Hepatitis C after Eradication of HCV Infection by Interferon Therapy

Changes in Hepatitis C Virus (HCV) Antibody Status in Patients with Chronic Hepatitis C after Eradication of HCV Infection by Interferon Therapy MAJOR ARTICLE Changes in Hepatitis C Virus (HCV) Antibody Status in Patients with Chronic Hepatitis C after Eradication of HCV Infection by Interferon Therapy Hidenori Toyoda, 1 Takashi Kumada, 1 Seiki

More information

ABNORMAL LEVELS OF LIVER ENzymes

ABNORMAL LEVELS OF LIVER ENzymes ORIGINAL CONTRIBUTION Hepatotoxicity Associated With Antiretroviral Therapy in Adults Infected With Human Immunodeficiency Virus and the Role of Hepatitis C or B Virus Infection Mark S. Sulkowski, MD David

More information

Evaluation of Interferon Treatment in Cirrhotic Patients with Hepatitis C

Evaluation of Interferon Treatment in Cirrhotic Patients with Hepatitis C Evaluation of Interferon Treatment in Cirrhotic Patients with Hepatitis C Tatsuya IDE, Michio SATA, Hiroshi SUZUKI, Shiroh MURASHIMA, Ichiroh MIYAJIMA, Miki SHIRACHI and Kyuichi TANIKAWA The Second Department

More information

: TP6.3 g dl, Alb4.3 g dl, GOT17 IU l, GPT26 IU l,

: TP6.3 g dl, Alb4.3 g dl, GOT17 IU l, GPT26 IU l, 5 Vol. 34, pp. 5 23, 2006 C IFN 0 2 : 8 4 20 63 986 990 C 993 S7 C A F2 IFN IFNa2a 9MIU 24W HCV-RNA 995 2 F HCV-RNA IFN 0 2004 5 S8 20 mm CT SPIO-MRI 6 TP6.3 g dl, Alb4.3 g dl, GOT7 IU l, GPT26 IU l, g-gtp40

More information

Over the past decade, the introduction of

Over the past decade, the introduction of MANAGEMENT OF CHRONIC HEPATITIS C IN HIV-INFECTED PATIENTS: CLINICAL EXPERIENCE WITH PEGYLATED INTERFERON α PLUS RIBAVIRIN Raymond T. Chung, MD* ABSTRACT Coinfection with hepatitis C virus (HCV) is common

More information

Treatment of HCV and HIV coinfection

Treatment of HCV and HIV coinfection Annals of Hepatology 2006; 5(Suppl. 1): S42-S48 Annals of Hepatology Treatment of HCV and HIV coinfection J. Alberto Juárez Navarro 1 Chronic infection with hepatitis C virus (HCV) affects 170 million

More information

The medical management of hepatitis C

The medical management of hepatitis C CLINICAL EXPERIENCE WITH PEGYLATED INTERFERON α-2a PLUS RIBAVIRIN FOR CHRONIC HEPATITIS C VIRUS INFECTION IN PATIENTS INFECTED WITH HIV: THE APRICOT STUDY Douglas T. Dieterich, MD* ABSTRACT Currently,

More information

Survival in patients with HIV infection and viral hepatitis B or C: a cohort study

Survival in patients with HIV infection and viral hepatitis B or C: a cohort study Survival in patients with HIV infection and viral hepatitis B or C: a cohort study Maurizio Bonacini a,d, Stan Louie b, Natalie Bzowej d and Amy Rock Wohl c Aim: To assess survival in patients with HIV

More information

HIV and Hepatitis C Virus Coinfection: Bad Bedfellows

HIV and Hepatitis C Virus Coinfection: Bad Bedfellows Perspective HIV and Hepatitis C Virus Coinfection: Bad Bedfellows Hepatitis C virus (HCV) infection is common in HIV-infected individuals and is responsible for increasing morbidity in these patients.

More information

Healthy Liver Cirrhosis

Healthy Liver Cirrhosis Gioacchino Angarano Clinica delle Malattie Infettive Università degli Studi di Foggia Healthy Liver Cirrhosis Storia naturale dell epatite HCVcorrelata in assenza di terapia Paestum 13-15 Maggio 24 The

More information

Clinical Infectious Diseases Advance Access published September 3, 2014

Clinical Infectious Diseases Advance Access published September 3, 2014 Clinical Infectious Diseases Advance Access published September 3, 2014 1 Acute hepatitis C virus infection in HIV+ MSM: Should we change our screening practice? Reiberger T. Division of Gastroenterology

More information

Update on HIV-HCV Epidemiology and Natural History

Update on HIV-HCV Epidemiology and Natural History Update on HIV-HCV Epidemiology and Natural History Jennifer Price, MD Assistant Clinical Professor of Medicine University of California, San Francisco Learning Objectives Upon completion of this presentation,

More information

INFECTION WITH GB VIRUS C AND REDUCED MORTALITY AMONG HIV-INFECTED PATIENTS

INFECTION WITH GB VIRUS C AND REDUCED MORTALITY AMONG HIV-INFECTED PATIENTS INFECTION WITH GB VIRUS C AND REDUCED MORTALITY AMONG HIV-INFECTED PATIENTS INFECTION WITH GB VIRUS C AND REDUCED MORTALITY AMONG HIV-INFECTED PATIENTS HANS L. TILLMANN, M.D., HANS HEIKEN, M.D., ADRIANA

More information

Direct acting anti-virals: the near future

Direct acting anti-virals: the near future Direct acting anti-virals: the near future Heiner Wedemeyer Hannover Medical School Germany Will IFN-free treatment be possible in the near future? Interferon-free regimens to treat hepatitis C What should

More information

Management of HIV/HCV Coinfection: An Update

Management of HIV/HCV Coinfection: An Update Management of HIV/HCV Coinfection: An Update Reprinted from The prn Notebook march 2004 Dr. James F. Braun, Editor-in-Chief Tim Horn, Executive Editor. Published in New York City by the Physicians Research

More information

Research Article Clinical Features of Adult Patients with Acute Hepatitis B Virus Infection Progressing to Chronic Infection

Research Article Clinical Features of Adult Patients with Acute Hepatitis B Virus Infection Progressing to Chronic Infection International Hepatology, Article ID 358206, 5 pages http://dx.doi.org/10.1155/2014/358206 Research Article Clinical Features of Adult Patients with Acute Hepatitis B Virus Infection Progressing to Chronic

More information

Hepatitis B Diagnosis and Management. Marion Peters University of California San Francisco

Hepatitis B Diagnosis and Management. Marion Peters University of California San Francisco Hepatitis B Diagnosis and Management Marion Peters University of California San Francisco COI Spouse works for Hoffmann-La Roche HBV is a life long, dynamic disease Changes over time Risk of end stage

More information

ORIGINAL INVESTIGATION. Age-Related Response to Interferon Alfa Treatment in Women vs Men With Chronic Hepatitis C Virus Infection

ORIGINAL INVESTIGATION. Age-Related Response to Interferon Alfa Treatment in Women vs Men With Chronic Hepatitis C Virus Infection ORIGINAL INVESTIGATION Age-Related to Interferon Alfa Treatment in Women vs Men With Chronic Hepatitis C Virus Infection Jun Hayashi, MD, PhD; Yasuhiro Kishihara, MD; Kumiko Ueno, MD; Kouzaburo Yamaji,

More information

Impact of HIV on Host-Virus Interactions during Early Hepatitis C Virus Infection

Impact of HIV on Host-Virus Interactions during Early Hepatitis C Virus Infection M A J O R A R T I C L E Impact of HIV on Host-Virus Interactions during Early Hepatitis C Virus Infection M. Danta, 1,9,a N. Semmo, 5,10,a P. Fabris, 5,8 D. Brown, 1 O. G. Pybus, 6 C. A. Sabin, 3 S. Bhagani,

More information

Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors.

Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix to: Thompson AJV; Expert panel representing the Gastroenterological

More information

Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users

Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users Jamalidoust et al. Virology Journal (2017) 14:127 DOI 10.1186/s12985-017-0797-2 RESEARCH Open Access Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit

More information

Genotype Dependence of Hepatitis C Virus Load Measurement in Commercially Available Quantitative Assays

Genotype Dependence of Hepatitis C Virus Load Measurement in Commercially Available Quantitative Assays JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 1999, p. 2525 2532 Vol. 37, No. 8 0095-1137/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Genotype Dependence of Hepatitis C

More information

Pegasys Ribavirin

Pegasys Ribavirin Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.01.08 Subsection: Anti-infective Agents Original Policy Date: January 1, 2006 Subject: Pegasys Ribavirin

More information

The Influence of HCV Coinfection on Clinical, Immunological and Virological Responses to HAART in HIV-Patients

The Influence of HCV Coinfection on Clinical, Immunological and Virological Responses to HAART in HIV-Patients BJID 2008; 12 (June) 173 The Influence of HCV Coinfection on Clinical, Immunological and Virological Responses to HAART in HIV-Patients Ricardo A. Carmo 1,2, Mark D.C. Guimarães 3, Alexandre S. Moura 2,

More information

Prediction of Hepatocellular Carcinoma Incidence Risk by Ultrasound Elastography

Prediction of Hepatocellular Carcinoma Incidence Risk by Ultrasound Elastography 2235-1795/14/0031-0001$39.50/0 1 Editorial Prediction of Hepatocellular Carcinoma Incidence Risk by Ultrasound Elastography Prof. M. Kudo Editor Liver Cancer In patients with chronic hepatitis and continuous

More information

906 CID 2005:41 (15 September) HIV/AIDS

906 CID 2005:41 (15 September) HIV/AIDS HIV/AIDS BRIEF REPORT Hepatitis C Virus Infection in HIV Type 1 Infected Individuals Does Not Accelerate a Decrease in the CD4 + Cell Count but Does Increase the Likelihood of AIDS-Defining Events Justin

More information

The HCV pipeline: Will IFN-free treatment be possible? Heiner Wedemeyer. Hannover Medical School Germany

The HCV pipeline: Will IFN-free treatment be possible? Heiner Wedemeyer. Hannover Medical School Germany : Will IFN-free treatment be possible? Heiner Wedemeyer Hannover Medical School Germany Interferon-free regimens to treat hepatitis C What should be the goal of interferon-free treatment regimens: Sustained

More information

Relative predictive factors for hepatocellular carcinoma after HBeAg seroconversion in HBV infection

Relative predictive factors for hepatocellular carcinoma after HBeAg seroconversion in HBV infection PO Box 2345, Beijing 123, China World J Gastroenterol 25;11(43):6848-6852 www.wjgnet.com World Journal of Gastroenterology ISSN 17-9327 wjg@wjgnet.com E L S E V I E R 25 The WJG Press and Elsevier Inc.

More information

Performance of an automated system for quantification of hepatitis C virus RNA

Performance of an automated system for quantification of hepatitis C virus RNA Journal of Virological Methods 86 (2000) 55 60 www.elsevier.com/locate/jviromet Performance of an automated system for quantification of hepatitis C virus RNA Anne Marie Roque Afonso a, *, Josiane Didier

More information

Peginterferon alpha-2b plus ribavirin for chronic hepatitis C virus mixed genotype infection

Peginterferon alpha-2b plus ribavirin for chronic hepatitis C virus mixed genotype infection ORIGINAL ARTICLE July-August, Vol. 13 No. 4, 2014: 350-355 Peginterferon alpha-2b plus ribavirin for chronic hepatitis C virus mixed genotype infection Ching-Chung Lin,*,, Chia-Hsien Wu, Huan-Lin Chen,

More information

Sequential Serum Hepatitis C Viral RNA Levels Longitudinally Assessed by Branched DNA Signal Amplification

Sequential Serum Hepatitis C Viral RNA Levels Longitudinally Assessed by Branched DNA Signal Amplification Sequential Serum Hepatitis C Viral RNA Levels Longitudinally Assessed by Branched DNA Signal Amplification STUART C. GORDON, 1,2 PETER J. DAILEY, 3 ANN L. SILVERMAN, 1,2 BILAL A. KHAN, 1 VALLISTRAM P.

More information

Natural History of Chronic Hepatitis B

Natural History of Chronic Hepatitis B Natural History of Chronic Hepatitis B Anna SF Lok, MD Alice Lohrman Andrews Professor in Hepatology Director of Clinical Hepatology Assistant Dean for Clinical Research University of Michigan Ann Arbor,

More information

Role of Hepatitis B Virus Genotypes in Chronic Hepatitis B Exacerbation

Role of Hepatitis B Virus Genotypes in Chronic Hepatitis B Exacerbation BRIEF REPORT Role of Hepatitis B Virus Genotypes in Chronic Hepatitis B Exacerbation Man-Fung Yuen, 1 Erwin Sablon, 2 Danny Ka-Ho Wong, 1 He-Jun Yuan, 1 Benjamin Chun-Yu Wong, 1 Annie On-On Chan, 1 and

More information

HBV Core and Core-Related Antigen Quantitation in Chinese Patients with. Chronic Hepatitis B Genotype B and C Virus Infection

HBV Core and Core-Related Antigen Quantitation in Chinese Patients with. Chronic Hepatitis B Genotype B and C Virus Infection Title page HBV Core and Core-Related Antigen Quantitation in Chinese Patients with Chronic Hepatitis B Genotype B and C Virus Infection Short Title: Quantitation of HBc and HBcrAg in Chinese patients Akinori

More information

Antiviral therapy guidelines for the general population

Antiviral therapy guidelines for the general population Discussion 10 Chapter 10 Hepatitis C a worldwide problem More than 170 million people worldwide suffer from chronic hepatitis C. Its prevalence is 2% in industrialized countries. 1 Approximately 20% of

More information

Effects and Outcomes of Interferon Treatment in Japanese Hepatitis C Patients

Effects and Outcomes of Interferon Treatment in Japanese Hepatitis C Patients Yamasaki et al. BMC Gastroenterology 212, 12:139 RESEARCH ARTICLE Open Access Effects and Outcomes of Interferon Treatment in Japanese Hepatitis C Patients Kazumi Yamasaki 1,6*, Mayumi Tomohiro 2, Yumiko

More information

Hepatitis C and HIV. Stanislas Pol

Hepatitis C and HIV. Stanislas Pol Hepatitis C and HIV Stanislas Pol Unité d Hépatologie, Hôpital Cochin Inserm U1223 & USM20 Institut Pasteur Université Paris Descartes Paris, France stanislas.pol@cch.aphp.fr Lisboa, 30 January 2017 Disclosures

More information

hepatitis B virus B 15% 25 HBsAg B HBV HBsAg 15% 20% HBV HBV 90% 16 HIV HBV

hepatitis B virus B 15% 25 HBsAg B HBV HBsAg 15% 20% HBV HBV 90% 16 HIV HBV hepatitis virus HV 20 15% 25 20 30 HV HsAg 3 5 100 HV 15% 20% HV HsAg HV HV HV 90% 16 5% HV 10 59 http://www.aids-care.org.tw HV CD8 73% 98% HV 90% HV HsAg 6 10% HsAg 0.5% 1% HV HV HV HV HCV TNF- TNF-

More information

Clinicopathological Conference: Hepatitis C in a Patient With Human Immunodeficiency Virus Infection

Clinicopathological Conference: Hepatitis C in a Patient With Human Immunodeficiency Virus Infection Hepatology at the Millennium Clinicopathological Conference: Hepatitis C in a Patient With Human Immunodeficiency Virus Infection LORNA M. DOVE, JUDY ALONZO, AND TERESA L. WRIGHT Liver disease is common

More information

HBV, HCV / HIV Coinfection 衛生署疾病管制局中區傳染病防治醫療網王任賢指揮官

HBV, HCV / HIV Coinfection 衛生署疾病管制局中區傳染病防治醫療網王任賢指揮官 HBV, HCV / HIV Coinfection 衛生署疾病管制局中區傳染病防治醫療網王任賢指揮官 Epidemiology HBV endemic in Africa/Asia/South America low prevalence in the west HCV high prevalence in Europe/USA/North and South Africa increasing

More information

29th Viral Hepatitis Prevention Board Meeting

29th Viral Hepatitis Prevention Board Meeting 29th Viral Hepatitis Prevention Board Meeting Madrid, November 2006 Treatment of chronic hepatitis B José M. Sánchez-Tapias Liver Unit Hospital Clínic University of Barcelona Spain CHRONIC HBV INFECTION

More information

Immunity to Viruses. Patricia Fitzgerald-Bocarsly September 25, 2008

Immunity to Viruses. Patricia Fitzgerald-Bocarsly September 25, 2008 Immunity to Viruses Patricia Fitzgerald-Bocarsly September 25, 2008 The Immune System Deals with a Huge Range of Pathogens Roitt, 2003 Immune Responses to Viruses Viruses are dependent on the host cell

More information

Hepatitis C Virus Genotype 2 may not be detected by the Cobas AmpliPrep/Cobas. TaqMan HCV Test, version 1.0

Hepatitis C Virus Genotype 2 may not be detected by the Cobas AmpliPrep/Cobas. TaqMan HCV Test, version 1.0 JCM Accepts, published online ahead of print on 25 September 2013 J. Clin. Microbiol. doi:10.1128/jcm.02102-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 2 Hepatitis C Virus

More information

Antiviral Therapy 11: Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan 2

Antiviral Therapy 11: Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan 2 Antiviral Therapy 11:985 994 A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre

More information

HBV in HIV Forgotten but not Gone

HBV in HIV Forgotten but not Gone Activity Code FA376 HBV in HIV Forgotten but not Gone Richard K. Sterling, MD, MSc VCU Hepatology Professor of Medicine Chief, Section of Hepatology Virginia Commonwealth University Learning Objectives

More information

Hepatitis C virus (HCV) is estimated to infect more than REVIEW

Hepatitis C virus (HCV) is estimated to infect more than REVIEW CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2011;9:923 930 REVIEW Effects of a Sustained Virologic Response on Outcomes of Patients With Chronic Hepatitis C VIVIAN NG* and SAMMY SAAB*, *Department of Medicine,

More information

W ith an estimated million people worldwide

W ith an estimated million people worldwide 141 ORIGINAL ARTICLE Clinical evaluation of the COBAS Amplicor HBV monitor test for measuring serum HBV DNA and comparison with the Quantiplex branched DNA signal amplification assay in Taiwan C-Y Dai,

More information

ORIGINAL INVESTIGATION. Treatment for Hepatitis C Virus in Human Immunodeficiency Virus Infected Patients

ORIGINAL INVESTIGATION. Treatment for Hepatitis C Virus in Human Immunodeficiency Virus Infected Patients Treatment for Hepatitis C Virus in Human Immunodeficiency Virus Infected Patients Clinical Benefits and Cost-effectiveness ORIGINAL INVESTIGATION Felicitas C. Kuehne, MSc; Ullrich Bethe, MD, MSc; Kenneth

More information

coinfected patients predicts HBsAg clearance during long term exposure to tenofovir

coinfected patients predicts HBsAg clearance during long term exposure to tenofovir Measurement of serum HBsAg in HIV/HBV coinfected patients predicts HBsAg clearance during long term exposure to tenofovir Zulema Plaza 1, Antonio Aguilera 2, Alvaro Mena 3, Luz Martín-Carbonero 1, Eugenia

More information

Molecular Epidemiology of Hepatitis D Virus Infection among Injecting Drug Users with and without Human Immunodeficiency Virus Infection in Taiwan

Molecular Epidemiology of Hepatitis D Virus Infection among Injecting Drug Users with and without Human Immunodeficiency Virus Infection in Taiwan JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 2011, p. 1083 1089 Vol. 49, No. 3 0095-1137/11/$12.00 doi:10.1128/jcm.01154-10 Copyright 2011, American Society for Microbiology. All Rights Reserved. Molecular Epidemiology

More information

With the advent of highly active antiretroviral therapy

With the advent of highly active antiretroviral therapy CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2010;8:1070 1076 Similar Progression of Fibrosis Between HIV/HCV Infected and HCV Infected Patients: Analysis of Paired Liver Biopsy Samples RICHARD K. STERLING,*,

More information

Virological Tools and Monitoring in the DAA Era

Virological Tools and Monitoring in the DAA Era Virological Tools and Monitoring in the DAA Era Prof. Jean-Michel Pawlotsky, MD, PhD National Reference Center for Viral Hepatitis B, C and delta Department of Virology & INSERM U955 Henri Mondor Hospital

More information

Laboratory for Clinical and Biological Studies, University of Miami Miller School of Medicine, Miami, FL, USA.

Laboratory for Clinical and Biological Studies, University of Miami Miller School of Medicine, Miami, FL, USA. 000000 00000 0000 000 00 0 bdna () 00000 0000 000 00 0 Nuclisens () 000 00 0 000000 00000 0000 000 00 0 Amplicor () Comparison of Amplicor HIV- monitor Test, NucliSens HIV- QT and bdna Versant HIV RNA

More information

DTD 1. Hepatitis C and HIV. Douglas T. Dieterich, MD Associate Professor of Medicine NYU School of Medicine

DTD 1. Hepatitis C and HIV. Douglas T. Dieterich, MD Associate Professor of Medicine NYU School of Medicine DTD 1 Hepatitis C and HIV Douglas T. Dieterich, MD Associate Professor of Medicine NYU School of Medicine DTD 2 Issues Similarities between HIV and HCV Incidence/prevalence of co-infection Overlapping

More information

H epatitis C virus (HCV) has emerged as the

H epatitis C virus (HCV) has emerged as the 601 REVIEW Hepatitis C and HIV-1 coinfection A H Mohsen, P Easterbrook, C B Taylor, S Norris... Hepatitis C virus (HCV) has emerged as the cause of the second major epidemic of viral infection after human

More information

Case Rep Gastroenterol 2010;4: DOI: /

Case Rep Gastroenterol 2010;4: DOI: / 261 Very-Low-Dose Pegylated Interferon α2a Plus Ribavirin Therapy for Advanced Liver Cirrhosis Type C: A Possible Therapeutic Alternative without Splenic Intervention Shogo Ohkoshi Satoshi Yamagiwa Masahiko

More information

Treatment of Hepatitis C in HIV-Coinfected Patients. Vincent Soriano Department of Infectious Diseases Hospital Carlos III Madrid, Spain

Treatment of Hepatitis C in HIV-Coinfected Patients. Vincent Soriano Department of Infectious Diseases Hospital Carlos III Madrid, Spain Treatment of Hepatitis C in HIV-Coinfected Patients Vincent Soriano Department of Infectious Diseases Hospital Carlos III Madrid, Spain Estimated no. of persons infected with HIV and hepatitis viruses

More information

La gestione corrente dell infezione cronica da HCV: la progressione verso la cirrosi. Simona Landonio I Div Mal inf H Sacco Milano

La gestione corrente dell infezione cronica da HCV: la progressione verso la cirrosi. Simona Landonio I Div Mal inf H Sacco Milano La gestione corrente dell infezione cronica da HCV: la progressione verso la cirrosi Simona Landonio I Div Mal inf H Sacco Milano HCV Natural History Viganò M et al Gastroenterology 27;133:835-842 Overall

More information

Intron A HEPATITIS B. Intron A (interferon alfa-2b) Description

Intron A HEPATITIS B. Intron A (interferon alfa-2b) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.03.01 Subject: Intron A Hepatitis B Page: 1 of 8 Last Review Date: September 18, 2015 Intron A HEPATITIS

More information

Viral Hepatitis Screening in HIV and Aging

Viral Hepatitis Screening in HIV and Aging Viral Hepatitis Screening in HIV and Aging Due to frequent overlap of risk factors for HIV and viral hepatitis, all HIV seropositive individuals should be screened for hepatitis A, hepatitis B, and hepatitis

More information

Viral hepatitis in patients living with HIV: can we still speak of special population?

Viral hepatitis in patients living with HIV: can we still speak of special population? Viral hepatitis in patients living with HIV: can we still speak of special population? Maurizio Bonacini, M.D., A.G.A.F. Mission Gastroenterology and Hepatology San Francisco, CA YES for HBV Excluded by

More information

Interferon and ribavirin therapy for chronic hepatitis C virus genotype 6: A comparison with genotype 1

Interferon and ribavirin therapy for chronic hepatitis C virus genotype 6: A comparison with genotype 1 Title Interferon and ribavirin therapy for chronic hepatitis C virus genotype 6: A comparison with genotype 1 Author(s) Hui, CK; Yuen, MF; Sablon, E; Chan, AOO; Wong, BCY; Lai, CL Citation Journal Of Infectious

More information

HIV Basics: Clinical Tests and Guidelines

HIV Basics: Clinical Tests and Guidelines HIV Basics: Clinical Tests and Guidelines ACTHIV 2010 Zelalem Temesgen MD Mayo Clinic Topics Baseline laboratory evaluation Laboratory monitoring through the continuum of care Patients not on antiretroviral

More information

Laboratory and Clinical Diagnosis of HCV Infection

Laboratory and Clinical Diagnosis of HCV Infection Laboratory and Clinical Diagnosis of HCV Infection Jean-Michel Pawlotsky,, MD, PhD Department of Virology (EA 3489) Henri Mondor Hospital University of Paris XII Créteil,, France I Nonspecific Liver Tests

More information

Current Standard of Care for Naïve HCV Patients (SVR)

Current Standard of Care for Naïve HCV Patients (SVR) Hepatitis C: Non-responders Nikunj Shah, MD Associate Professor of medicine University of Illinois Medical center 1 Current Standard of Care for Naïve HCV Patients (SVR) 1 8 8 6 53 45 4 6 52 46 4 2 2 Peg

More information

Performance Characteristics of the COBAS AMPLICOR Hepatitis C Virus MONITOR Test, Version 2.0

Performance Characteristics of the COBAS AMPLICOR Hepatitis C Virus MONITOR Test, Version 2.0 Clinical Chemistry / EVALUATION OF QUANTITATIVE HEPATITIS C VIRUS ASSAY Performance Characteristics of the COBAS AMPLICOR Hepatitis C Virus MONITOR Test, Version 2.0 Maria Erali, MS, 1 Edward R. Ashwood,

More information

High Levels of Hepatitis B Virus After the Onset of Disease Lead to Chronic Infection in Patients With Acute Hepatitis B

High Levels of Hepatitis B Virus After the Onset of Disease Lead to Chronic Infection in Patients With Acute Hepatitis B MAJOR ARTICLE High Levels of Hepatitis B Virus After the Onset of Disease Lead to Chronic Infection in Patients With Acute Hepatitis B Hiroshi Yotsuyanagi, 1,a Kiyoaki Ito, 2,5,a Norie Yamada, 1,3,4 Hideaki

More information

Pegasys Pegintron Ribavirin

Pegasys Pegintron Ribavirin Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.01.47 Subsection: Anti-infective nts Original Policy Date: January 1, 2019 Subject: Pegasys Pegintron

More information

Interaction between HIV-1 and HCV infections: towards a new entity?

Interaction between HIV-1 and HCV infections: towards a new entity? Journal of Antimicrobial Chemotherapy (2004) 53, 936 946 DOI: 10.1093/jac/dkh200 Advance Access publication 29 April 2004 Interaction between HIV-1 and HCV infections: towards a new entity? Maria Winnock

More information

Molecular Diagnosis Future Directions

Molecular Diagnosis Future Directions Molecular Diagnosis Future Directions Philip Cunningham NSW State Reference Laboratory for HIV/AIDS & Molecular Diagnostic Medicine Laboratory, SydPath St Vincent s Hospital Sydney Update on Molecular

More information

Hepatitis C virus (HCV) infection frequently

Hepatitis C virus (HCV) infection frequently Le Infezioni in Medicina, n. 1, 29-33, Lavori originali Biochemical response to interferon of chronic hepatitis in drug-addict patients infected with human immunodeficiency virus Risposta all interferone

More information

Management of CHC G1 patients who are relapsers or non-responders to Peg IFN and RBV therapy: Wait or Triple Therapy?

Management of CHC G1 patients who are relapsers or non-responders to Peg IFN and RBV therapy: Wait or Triple Therapy? Management of CHC G1 patients who are relapsers or non-responders to Peg IFN and RBV therapy: Wait or Triple Therapy? Prof. Teerha Piratvisuth NKC Institute of Gastroenterology and Hepatology Prince of

More information

D. Posthouwer 1 K. Fischer 1,2 N. de Heusden 1 E.P. Mauser-Bunschoten 1

D. Posthouwer 1 K. Fischer 1,2 N. de Heusden 1 E.P. Mauser-Bunschoten 1 Pegylated interferon and ribavirin combination therapy for chronic hepatitis C in patients with inherited bleeding disorders: a single-center experience 9 D. Posthouwer 1 K. Fischer 1,2 N. de Heusden 1

More information

The Hepatitis B-e antigen-positive

The Hepatitis B-e antigen-positive The Hepatitis B-e antigen-positive Dental Student Developing an Equitable Policy Hepatitis B Virus Serology 1 HBsAg A protein on the surface of HBV; it can be detected in high levels in serum during acute

More information

8 Larissa International Congress of Internal Medicine

8 Larissa International Congress of Internal Medicine 8 Larissa International Congress of Internal Medicine Larissa, 18 th March 2016 IBD & Viral Hepatitis Alessio Aghemo, MD, PhD Division of Gastroenterology and Hepatology Fondazione IRCCS Ca Granda Ospedale

More information

Fulminant hepatic failure in acute hepatitis C: increased risk in chronic carriers of hepatitis B virus

Fulminant hepatic failure in acute hepatitis C: increased risk in chronic carriers of hepatitis B virus Gut 1999;45:613 617 613 Liver Research Unit, Chang Gung Memorial Hospital and Medical College, Taipei, Taiwan C M Chu CTYeh Y F Liaw Correspondence to: Dr C M Chu, Liver Research Unit, Chang Gung Memorial

More information

Long-term follow-up of patients with chronic hepatitis C with sustained virologic response to interferon

Long-term follow-up of patients with chronic hepatitis C with sustained virologic response to interferon ORIGINAL ARTICLE Long-term follow-up of patients with chronic hepatitis C with sustained virologic response to interferon Authors Sandro da Costa Ferreira, MD 1 Marcos de Vasconcelos Carneiro, MD 1 Fernanda

More information

Coinfection with HIV and Hepatitis C Virus in Injection Drug Users and Minority Populations

Coinfection with HIV and Hepatitis C Virus in Injection Drug Users and Minority Populations SUPPLEMENT ARTICLE Coinfection with HIV and Hepatitis C Virus in Injection Drug Users and Minority Populations Doris B. Strader Department of Medicine, Division of Gastroenterology/Hepatology, Fletcher

More information

Hepatitis D. Challenges in 2018

Hepatitis D. Challenges in 2018 Hepatitis D Challenges in 2018 Heiner Wedemeyer Essen University Hospital, Germany Germany Disclosures Honoraria for consulting or speaking (last 5 years): Abbott, AbbVie, Abivax, BMS, Boehringer Ingelheim,

More information

Hepatitis C - results in real life

Hepatitis C - results in real life Hepatitis C - results in real life Robert Flisiak Department of Infectious Diseases and Hepatology Medical University of Białystok, Poland 10th PHC Paris, 30-31 January 2017 Disclosures Advisor and/or

More information

The Changing World of Hepatitis C

The Changing World of Hepatitis C The Changing World of Hepatitis C Alnoor Ramji Gastroenterology & Hepatology Clinical Associate Professor Division of Gastroenterology University Of British Columbia St. Paul s Hospital Site Disclosures

More information

Intron A Hepatitis C. Intron A (interferon alfa-2b) Description

Intron A Hepatitis C. Intron A (interferon alfa-2b) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.01.05 Subject: Intron A Hepatitis C Page: 1 of 5 Last Review Date: November 30, 2018 Intron A Hepatitis

More information

HEPATITIS C VIRUS GENOTYPING IN CHRONIC HEPATITIS C PATIENTS

HEPATITIS C VIRUS GENOTYPING IN CHRONIC HEPATITIS C PATIENTS HEPATITIS C VIRUS GENOTYPING IN CHRONIC HEPATITIS C PATIENTS I. Qattan Centres for Hepatology, Royal Free & University College Medical School, London V. Emery Department of Virology, Royal Free & University

More information

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE CORRELATION BETWEEN SERUM AMINOTRANFERASE LEVELS AND HCV RNA LOAD IN HEPATITIS C VIRUS RELATED CHRONIC LIVER DISEASE. SINGH J 1, CHHINA

More information

Therapeutic strategies for immune reconstitution in acquired immunodeficiency syndrome

Therapeutic strategies for immune reconstitution in acquired immunodeficiency syndrome 30 1, 1, 2, 3 1. ( ), 201508; 2., 200040; 3., 200032 : ( AIDS) ( HIV) 20 90,,,,,, AIDS, CD4 + T ( CTL), HIV, : ; ; Therapeutic strategies for immune reconstitution in acquired immunodeficiency syndrome

More information

Should Elderly CHC Patients (>70 years old) be Treated?

Should Elderly CHC Patients (>70 years old) be Treated? Should Elderly CHC Patients (>70 years old) be Treated? Deepak Amarapurkar Consultant Gastroenterologist & Hepatologist Bombay Hospital & Medical Research Center, Mumbai & Jagjivanram Western Railway Hospital,

More information

Viral Hepatitis Diagnosis and Management

Viral Hepatitis Diagnosis and Management Viral Hepatitis Diagnosis and Management CLINICAL BACKGROUND Viral hepatitis is a relatively common disease (25 per 100,000 individuals in the United States) caused by a diverse group of hepatotropic agents

More information

Hepatitis Delta. Vicente Soriano Infectious Diseases Unit La Paz University Hospital & IdiPAZ Madrid, Spain

Hepatitis Delta. Vicente Soriano Infectious Diseases Unit La Paz University Hospital & IdiPAZ Madrid, Spain Hepatitis Delta Vicente Soriano Infectious Diseases Unit La Paz University Hospital & IdiPAZ Madrid, Spain Disclosures Member of speaker bureau and advisory board for: Roche, Boehringer, Gilead, Viiv,

More information

CASE REPORT. Introduction

CASE REPORT. Introduction doi: 1.2169/internalmedicine.1856-18 Intern Med Advance Publication http://internmed.jp CASE REPORT Glecaprevir and Pibrentasvir for Japanese Patients with Human Immunodeficiency Virus and Genotype 3 Hepatitis

More information

L\\\\\\1 V\\ High dose interferon treatment in chronic hepatitis C. Group A. Group B. Dosage. Treatment period

L\\\\\\1 V\\ High dose interferon treatment in chronic hepatitis C. Group A. Group B. Dosage. Treatment period SI 14 Gut 1993; supplement: SI 14-S118 Institute of Medical Science, School ofmedicine, St Marianna University, Japan S Iino Correspondence to: Dr S Iino, Institute of Medical Science, School of Medicine,

More information

Follow-up of patients with SVR Lawrence Serfaty Service d Hépatologie, UMR_S 938 Hôpital Saint-Antoine Université Pierre&Marie Curie Paris, France

Follow-up of patients with SVR Lawrence Serfaty Service d Hépatologie, UMR_S 938 Hôpital Saint-Antoine Université Pierre&Marie Curie Paris, France 9th Paris Hepatitis Conference, January 11-12, 2016 Follow-up of patients with SVR Lawrence Serfaty Service d Hépatologie, UMR_S 938 Hôpital Saint-Antoine Université Pierre&Marie Curie Paris, France Disclosures

More information

Caution: Reactivation of Hepatitis B during Hepatitis C Treatment with Direct-Acting Antiviral Therapy

Caution: Reactivation of Hepatitis B during Hepatitis C Treatment with Direct-Acting Antiviral Therapy Caution: Reactivation of Hepatitis B during Hepatitis C Treatment with Direct-Acting Antiviral Therapy Anjana A. Pillai, Emory University Frank A Anania, Emory University Brian L. Pearlman, Emory University

More information

Hepatitis C No Barriers to Cure

Hepatitis C No Barriers to Cure 2018 Digestive Diseases Conference Kansas Hepatitis C No Barriers to Cure Dr. Mauricio Lisker Melman Professor of Medicine Director Hepatology Program Division of Gastroenterology Disclosure The following

More information

Genotype 4. Sanaa Kamal, M.D., Ph.D. Professor. Ain Shams University, Cairo, Egypt Tufts School of Medicine

Genotype 4. Sanaa Kamal, M.D., Ph.D. Professor. Ain Shams University, Cairo, Egypt Tufts School of Medicine Optimal Therapy in Hepatitis C Genotype 4 Sanaa Kamal, M.D., Ph.D. Professor Ain Shams University, Cairo, Egypt Tufts School of Medicine Boston; USA HCV Genotype 4 True or False HCV-G4 is limited to Africa

More information

Hepatitis A virus (HAV) infection that is transmitted

Hepatitis A virus (HAV) infection that is transmitted Comparative Effectiveness of Two Doses Versus Three Doses of Hepatitis A Vaccine in Human Immunodeficiency Virus Infected and -Uninfected Men Who Have Sex With Men Yu-Tzu Tseng, 1 Sui-Yuan Chang, 2,3 Wen-Chun

More information

Solomon Taye 1,2* and Mekuria Lakew 2

Solomon Taye 1,2* and Mekuria Lakew 2 Taye and Lakew BMC Immunology 213, 14:23 RESEARCH ARTICLE Open Access Impact of hepatitis C virus co-infection on HIV patients before and after highly active antiretroviral therapy: an immunological and

More information

Immunodeficiency. (2 of 2)

Immunodeficiency. (2 of 2) Immunodeficiency (2 of 2) Acquired (secondary) immunodeficiencies More common Many causes such as therapy, cancer, sarcoidosis, malnutrition, infection & renal disease The most common of which is therapy-related

More information